CLOBEX Reviews (CLOBETASOL PROPIONATE)

Average Rating: 5.0 (2 Ratings)

Filter Results

Compare CLOBEX with similar:

 Type: Rx Drug

  

CLOBEX  (CLOBETASOL PROPIONATE):  Clobetasol is used in adults to treat moderate to severe plaque psoriasis. Clobetasol reduces the swelling, itching and redness that can occur with this condition. This medication is a very strong (super-high-potency) corticosteroid. This medication is not recommended for use in children younger than 18 years of age due to an increased risk of side effects. Ask the doctor or pharmacist for details.   FDA Approval Date: 2003-07-24 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Age from youngest to oldest (reviews with no age reported listed first).

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR CLOBEXCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 5  Eczema None I suffer from periodic flare-ups of eczema on my arms and hands. I have patches of red, angry skin that are very stubborn. After applying Clobex (0.05%), you can literally watch the redness dissipate before your eyes! It goes from bright red to what I describe as looking like almost healed bruises. I use this drug concurrently with Locoid Lipocream (0.1%). M 34 5 days
3X day
4/7/2013
Email
 5  psoriasis Awesome product! I had plaque psoriasis over approximately 70% of my body and the only spots I have left are on my elbows. Those are so tiny you can barely see them. M 37 3 years
2X day
1/1/2011
  

CLOBEX  (CLOBETASOL PROPIONATE):  Clobetasol is used in adults to treat moderate to severe plaque psoriasis. Clobetasol reduces the swelling, itching and redness that can occur with this condition. This medication is a very strong (super-high-potency) corticosteroid. This medication is not recommended for use in children younger than 18 years of age due to an increased risk of side effects. Ask the doctor or pharmacist for details.   FDA Approval Date: 2003-07-24 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP